Herranz Lab News

Congrats to Tanaya on her great editorial!

https://pubmed.ncbi.nlm.nih.gov/39445418

https://rutgershealth.org/chancellor/chancellor-awards

Dr. Herranz contributes to comprehensive review on Acute Lymphoblastic Leukemia published in Nature Reviews Disease Primers

https://pubmed.ncbi.nlm.nih.gov/38871740

Tanaya is one of the 2024 awardees of the Alex’s Lemonade Stand Foundation (ALSF) Pediatric Oncology Student Training (POST) program. This is an exciting opportunity for Tanaya to keep getting hands-on training on pediatric leukemia research in vivo, congrats!!

We are thrilled to receive an NCI R01 ($1.8M/5 years) and an ALSF R Award ($800K/4 years) to study the role of Pyruvate Kinase in both adult or pediatric T-ALL!

Thanks so much for your support!!

https://www.cinj.org/awards-totaling-26-million-support-exploration-therapeutic-strategy-adult-and-pediatric-t-cell

The Herranz Lab welcomes Gwen as a new undergrad intern!

Congratulations to Komal for her very neat editorial!

https://pubmed.ncbi.nlm.nih.gov/38235506/

Welcome to the lab, Rodri!

So happy to receive one of their Alex’s Million Miles grant again!

This 2-year and $500K collaborative grant (together with our good friend Dr. David Dominguez-Sola at Icahn School of Medicine at Mount Sinai) will allow us to investigate the role of INO80 in difficult-to-treat lymphomas.

https://www.cinj.org/500k-grant-supports-exploration-therapies-difficult-treat-lymphomas